Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
47°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
Tickers
AAPL
AGTC
AKUS
BKKT
Tags
BTRS
OIIM
MSPR
From
Benzinga
Editas Medicine's Return On Capital Employed Insights
August 10, 2022
Tickers
EDIT
Tags
Earnings
Market News
Benzinga
From
Benzinga
Why Editas Medicine Was Winning on Wednesday
August 03, 2022
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
RHHBY
ICPT
MCRB
From
Benzinga
Editas Medicine: Q2 Earnings Insights
August 03, 2022
Tickers
EDIT
Tags
News
Benzinga
EDIT
From
Benzinga
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
Market News
CRSP
BLUE
From
Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
Tickers
BEAM
BIIB
CRSP
EDIT
Tags
VRTX
BIIB
Market News
From
InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
Tickers
AMZN
BEAM
BIIB
CRSP
Tags
EBAY
VRTX
LGVN
From
InvestorPlace
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
July 08, 2022
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
VRTX
BLUE
CRSP
From
Motley Fool
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
Analyst Color
Briefs
Biotech
From
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Tickers
ADVM
AIKI
DCTH
DNA
Tags
FDA
JAZZ
KRBP
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 07, 2022
Tickers
AIKI
BAOS
BCAN
CETX
Tags
YMTX
EDIT
BAOS
From
InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
June 07, 2022
Tickers
AERC
AUVI
BCAN
CETX
Tags
HLBZ
AERC
KSS
From
Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Tickers
ARKG
ARKK
BNR
DNA
Tags
ARKG
Market News
Today's Market
From
InvestorPlace
Editas Medicine's Return On Capital Employed Insights
May 19, 2022
Tickers
EDIT
Tags
Earnings
Market News
Benzinga
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
^IXIC
Market News
NTLA
From
Motley Fool
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
LGVN
PRPH
BTTX
From
Benzinga
These 5-Stock Samplers Have Gotten Whacked. And That's OK
May 13, 2022
Tickers
AAPL
ABNB
AMGN
AMZN
Tags
PTON
AVAV
LVGO
From
Motley Fool
Expert Ratings for Editas Medicine
May 09, 2022
Tickers
EDIT
Tags
Analyst Ratings
EDIT
Benzinga
From
Benzinga
Editas Medicine: Q1 Earnings Insights
May 04, 2022
Tickers
EDIT
Tags
Earnings
BZI/Recaps
Market News
From
Benzinga
Editas Medicine Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EDIT
Tags
News
Benzinga
EDIT
From
Benzinga
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
April 26, 2022
Tickers
EDIT
Tags
General
Small Cap
Market News
From
Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
NTLA
Market News
CRSP
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
CRSP
Recent Press Releases
EDIT
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
BMBL
MSFT
N
From
Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
Tags
General
Movers
Legal
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
EPZM
Market News
ITCI
From
Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Tickers
AREB
ATXI
AVGR
AVIR
Tags
SNII
Pre/Market Movers
VEON
From
Benzinga
Expert Ratings For Editas Medicine
February 25, 2022
Tickers
EDIT
Tags
EDIT
Market News
BZI/AAR
From
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
CDXS
Earnings
MMSI
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.